© 2019 PRIVATE HEALTH MANAGEMENT

Cancer Client Success Stories

LUNG CANCER

 

PRESENTATION

  • George, 59, was diagnosed with stage IVb non-small cell lung cancer with adrenal and osseous metastases

  • George had been advised to go on hospice and make end-of-life arrangements. Instead, he called us.

 

OUR ACTIONS & IMPACT 

  • We recommended genetic testing, which revealed information that made him eligible for a clinical trial that we identified

  • We identified an expert oncologist to manage his care

  • George responded and tolerated the treatment well, and remained on the clinical trial for a full year until he had progression evident by bone metastases

  • George then enrolled in an additional clinical trial (recommended by PHM) after completing radiotherapy for bone metastases. He was stable for eight months, until disease progression was evident upon imaging. 

  • Previous genetic testing qualified him for another Private Health Management-identified clinical trial

  • We collaborated with the expert oncologist running the trial to overcome the multiple obstacles that would have prevented the client’s admittance to the trial

 

RESULTS

  • George enrolled in 3 clinical trials over 5 years with successful outcomes

  • Today, George has very few constraints and often forgets that he has cancer

GEORGE

 

METASTATIC MELANOMA

 

INCOMING SITUATION

  • Joanna, 28, was diagnosed with metastatic melanoma and told to “get her affairs in order”Instead, she called us.

 

OUR ACTIONS & IMAPCT

  • Within 24 hours of being contacted, we scheduled an appointment with world-leading melanoma expert at major academic medical center

  • We had tumor tissue analyzed for cancer-related genomic mutations that could make her eligible for newly-approved mutation-targeting drugs

  • Key genomic mutations found to be present

  • We encouraged her to consider enrolling in a clinical trial that included 2 FDA-approved mutation-targeting drugs and a promising experimental immune-based drug

  • She enrolled in the clinical trial, ensuring that she receives all three drugs free of charge

  • Annual cost of each the three drugs if her health insurance had to pay for them would have been over $345,000

 

 

RESULTS 

  • Joanna is symptom-free and thriving with no evidence of disease

  • Private Health Management saved $345,000 in drug costs annually

 

JOANNA